Add to your lists

Recommended Content

Picture of All-In Podcast

LA's Wildfire Disaster, Zuck Flips on Free Speech, Why Trump Wants Greenland

Jan. 11, 2025, 2:08 a.m.

No Paywall
Picture of Tech Investment Ideas

ASML's Strategy to Extend Moore's Law

Jan. 7, 2025, 9:50 a.m.

No Paywall
Picture of Platformer

OpenAI says it knows how to make superintelligence now

Jan. 7, 2025, 1:32 a.m.

Some Paywall
Picture of Tanay’s Newsletter

Comparing the Financials of Databricks and Snowflake

Dec. 30, 2024, 11:35 p.m.

No Paywall
Picture of The Entertainment Strategy Guy

The Future of TV or Just Another Netflix Hit?

Dec. 19, 2024, 12:10 a.m.

No Paywall
FinBrowser logo

How would you rate this source in terms of content quality?
Source Picture

Matt Gamber’s Biotech Newsletter

Picture of Matt Gamber’s Biotech Newsletter

Similiar Sources

Picture of Axial
Axial
Biotech - Analysis 8.0
Picture of BioCentury This Week
BioCentury This Week
Biotech - Analysis 8.0
Picture of Bioshares
Bioshares
Biotech - Analysis 8.0
Picture of Biotech Hangout - Spotify
Biotech Hangout - Spotify
Biotech - Analysis 8.0
Picture of BioTech Nation ... with Dr. Moira Gunn
BioTech Nation ... with Dr. Moira Gunn
Biotech - Analysis 8.0
Picture of Borlaug’s Substack
Borlaug’s Substack
Biotech - Analysis 9.0
Picture of BowTiedBiotech
BowTiedBiotech
Biotech - Analysis 8.5
Picture of Breaking Biotech
Breaking Biotech
Biotech - Analysis 9.0
Picture of The Century of Biology
The Century of Biology
Biotech - Analysis 9.0
Picture of Turning Rough Stones
Turning Rough Stones
Biotech - Analysis 8.0

Summary

Sector Biotech
Content Type Analysis
Website Substack
Paywall No

Ratings

Average Rating 9.0
Ratings 1
Your Rating Rate
Ranking 105

Content

Picture of Matt Gamber’s Biotech Newsletter

JPMorgan Healthcare Conference Recap, Part 2 (Nine New Ideas)

Jan. 22, 2025, 11:03 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

JPMorgan Healthcare Conference Recap, Part 1

Jan. 15, 2025, 11:02 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

An Idea I Have Never Written About Before

Jan. 10, 2025, 11:01 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

What I'll Be Watching At The JPMorgan Healthcare Conference

Jan. 8, 2025, 11:03 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

The Case For Biotech

Jan. 1, 2025, 11:02 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

Free Post: My 2025 "No Trades" Model Portfolio

Dec. 18, 2024, 11:02 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

My 2025 Biotech Investing Preview: Themes, Companies, Predicting The Future

Dec. 11, 2024, 11:02 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

How I'm Setting Up My Portfolio In 2025

Dec. 4, 2024, 11:03 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

Notable quotes and notes from November investor conferences.

Nov. 26, 2024, 11:03 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

Q3 2024 Earnings Call Recap, Part 2

Nov. 20, 2024, 11:01 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

Q3 2024 Earnings Call Recap, Part 1

Nov. 13, 2024, 11:02 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

FAQ: Why is there now a paid tier and what do I get?

Nov. 12, 2024, 11:01 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

Some Announcements! (And my Top 10 Positions as of November 1, 2024.)

Nov. 1, 2024, 11:03 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

My Top 10 Ideas As Of End of September 2024

Oct. 2, 2024, 11:01 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

My Top 10 Ideas As Of End of August 2024: Disclaimer: Not investment advice.

Sept. 3, 2024, 11:01 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

My Thoughts On 14 Different Q2 Earnings Calls: Disclaimer: Not investment advice.

Aug. 29, 2024, 11:02 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

My Top 10 Ideas As Of End of July 2024: Disclaimer: Not investment advice.

Aug. 1, 2024, 11:03 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

My Top 10 Ideas As Of End of June 2024: Disclaimer: Not investment advice.

June 28, 2024, 11:02 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

My Top 10 Ideas As Of End of May 2024: Disclaimer: Not investment advice. Do your own research. For informational purposes only. I reserve the right to change positions after publishing as events change. Position rankings are accurate as of pre-market 5/27/2024 when writing was completed.

May 28, 2024, 11:01 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

Podcast #2: PODD, ELEV, FGEN, AVDL: A quick 18 minute podcast with some thoughts on news from the last week. Companies Covered and Timestamps: $PODD (0:00) $ELEV (4:24) $FGEN (9:06) $AVDL (17:08) Outline PODD Earnings Thoughts U.S. on target International better than expected Q2 and Q3 are weak comps

May 13, 2024, 2:54 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

My Top 10 Ideas As Of End of April 2024 : Disclaimer: Not investment advice. Do your own research. For informational purposes only. I reserve the right to change positions after publishing as events change. Position rankings are accurate as of post-market 4/29/24 when writing was started. Two new names enter the Top 10 this month, and two leave…one because of a very nice run-up and buyout! Let’s begin.

May 1, 2024, 12:03 p.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

PODCAST #1: Insulet (PODD) & Iteos (ITOS): Hey everyone, trying something new!

May 1, 2024, 2:02 a.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

My Top 10 Ideas As Of End of March 2024, Part 2: Disclaimer: Not investment advice. Do your own research. For informational purposes only. I reserve the right to change positions after publishing as events change. Position rankings are accurate as of pre-market 3/25/24 when writing was completed. This is the second part of yesterday’s post!

March 28, 2024, 1:02 p.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

My Top 10 Ideas As Of End of March 2024, Part 1: Disclaimer: Not investment advice. Do your own research. For informational purposes only. I reserve the right to change positions after publishing as events change. Position rankings are accurate as of pre-market 3/25/24 when writing was completed. No time to waste this month as there has been some significant changes and if you have been reading the last two months you already know the deal so let’s get into it!

March 27, 2024, 1:02 p.m.

No Paywall
Picture of Matt Gamber’s Biotech Newsletter

My Top 10 Ideas As Of End of February 2024: Disclaimer: Not investment advice. Do your own research. For informational purposes only. I reserve the right to change positions after publishing as events change. Position rankings are accurate as of 2/28/24. Hello, this is my monthly update on my top biotech positions. I’ll keep it short and sweet here at the top: very low turnover with only one new name entering the list this month. That’s great! That means every new idea I’m finding isn’t impress

Feb. 28, 2024, noon

No Paywall